Tetrabenazine 25 mg Tablet PCD Pharma Franchise in Delhi

CNS & Neurology Medicine Supplier in Mumbai

Huntington’s Disease Treatment Tablet Distributor in Pune

Tetrabenazine 25 mg Stockist and Wholesale Dealer in Jaipur

Neurology Segment Pharmaceutical Franchise in Lucknow
Tetrabenazine Tablet Third-Party Manufacturing in Chandigarh

Home/Products /tetrabenazine-25mg-tablet

Tetrazine 25 Tablet

Composition : Tetrabenazine (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Tetrazine 25 Tablet contains Tetrabenazine 25mg, a dopamine-depleting agent used for the management of movement disorders. It helps in reducing symptoms such as involuntary movements, tics, and abnormal motor activity commonly seen in conditions like Huntington’s disease, hemiballismus, chorea, and tardive dyskinesia.

Tetrabenazine works by decreasing dopamine activity in the brain, helping to control excessive or uncontrolled body movements. It belongs to the neurology and CNS therapeutic segment, and is commonly prescribed by neurologists for symptomatic relief in hyperkinetic disorders.

Tetrazine 25 Tablet is widely demanded in hospitals, neuro clinics, and rehabilitation centers due to its essential role in neurological treatment care.

Available for PCD pharma franchise, bulk distribution, institutional supply, and third-party manufacturing, Tetrazine 25 is a high‑value specialty CNS medicine with consistent prescription demand and strong market potential.

Read More

About the Product

Tetrazine 25 Tablet contains Tetrabenazine 25mg, a dopamine-depleting agent used for the management of movement disorders. It helps in reducing symptoms such as involuntary movements, tics, and abnormal motor activity commonly seen in conditions like Huntington’s disease, hemiballismus, chorea, and tardive dyskinesia.

Tetrabenazine works by decreasing dopamine activity in the brain, helping to control excessive or uncontrolled body movements. It belongs to the neurology and CNS therapeutic segment, and is commonly prescribed by neurologists for symptomatic relief in hyperkinetic disorders.

Tetrazine 25 Tablet is widely demanded in hospitals, neuro clinics, and rehabilitation centers due to its essential role in neurological treatment care.

Available for PCD pharma franchise, bulk distribution, institutional supply, and third-party manufacturing, Tetrazine 25 is a high‑value specialty CNS medicine with consistent prescription demand and strong market potential.

Common side effects may include drowsiness, fatigue, restlessness, dizziness, nausea, insomnia, and depression. Some individuals may also experience tremors, anxiety, or changes in mood. Rarely, it may cause suicidal thoughts or worsening depression, and medical help should be sought if such symptoms appear.

Tetrazine 25 Tablet is indicated for the treatment of chorea associated with Huntington’s disease and other hyperkinetic movement disorders such as tardive dyskinesia, Tourette syndrome, and severe motor tics. It helps improve muscle control, reduces unwanted movements, and enhances daily functioning and quality of life.

Tetrazine 25 Tablet should be used strictly under medical supervision, especially in patients with a history of depression, suicidal behavior, or Parkinson’s disease. Avoid alcohol, sedatives, or CNS depressants while taking this medicine. Dose adjustments may be required in elderly patients and those with liver impairment. Do not stop the medication abruptly without consulting your doctor.

Store Tetrazine 25 Tablet in a cool, dry place below 25°C, away from heat, moisture, and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation